Literature DB >> 4315207

I. Cultivation conditions and mixed lymphocyte interaction of mouse peripheral lymphocytes.

P Häyry, V Defendi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4315207      PMCID: PMC1712701     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  15 in total

1.  Production of interferon by human leukocytes in vitro.

Authors:  H Strander; K Cantell
Journal:  Ann Med Exp Biol Fenn       Date:  1966

2.  Standardized nomenclature for inbred strains of mice: fourth listing.

Authors:  J Staats
Journal:  Cancer Res       Date:  1968-03       Impact factor: 12.701

3.  Cell kinetic studies in mixed leukocyte cultures: an in vitro model of homograft reactivity.

Authors:  F H Bach; H Bock; K Graupner; E Day; H Klostermann
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

4.  The occurrence and properties of leukocytosis and lymphocytosis-stimulating material in the supernatant fluids of Bordetella pertussis cultures.

Authors:  S I Morse; K K Bray
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

5.  Quantitative studies on the mixed lymphocyte interaction in rats. I. Conditions and parameters of response.

Authors:  D B Wilson
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

6.  Quantitative studies on the mixed lymphocyte interaction in rats. 3. Kinetics of the response.

Authors:  D B Wilson; P C Blyth JL NOWELL
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

7.  Quantitative studies on the mixed lymphocyte interaction in rats. II. Relationship of the proliferative response to the immunologic status of the donors.

Authors:  D B Wilson; W K Silvers; P C Nowell
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

8.  Further studies of the stimulation of DNA synthesis in cultures of spleen cell suspensions by homologous cells in inbred strains of mice and rats.

Authors:  R W Dutton
Journal:  J Exp Med       Date:  1965-10-01       Impact factor: 14.307

9.  Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity.

Authors:  D B Amos; F H Bach
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

10.  The mixed lymphocyte reaction: an in vitro test for tolerance.

Authors:  M R Schwarz
Journal:  J Exp Med       Date:  1968-05-01       Impact factor: 14.307

View more
  8 in total

1.  Lymphocyte activation. I. Expression of theta, H-2 and immunoglobulin determinants on lymphocytes stimulated by phytohaemagglutinin, pokeweed mitogen, concanavalin A or histocompatibility antigen.

Authors:  G Jones
Journal:  Clin Exp Immunol       Date:  1972-11       Impact factor: 4.330

2.  Phi-isoantigenic marker in phytohemagglutinin-responding mouse blood lymphocytes.

Authors:  L Andersson; P Häyry
Journal:  Experientia       Date:  1972-01-15

3.  Immunosuppression in murine malaria. I. General characteristics.

Authors:  B M Greenwood; J H Playfair; G Torrigiani
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

4.  [Mixed leukocyte culture for immunological donor selection].

Authors:  W Mempel
Journal:  Klin Wochenschr       Date:  1972-03-15

5.  Induction of the immune response to cell surface antigens in vitro.

Authors:  L A Manson; J C Palmer
Journal:  In Vitro       Date:  1975 Jul-Aug

6.  Indirect blastogenesis of peripheral blood leukocytes in experimental gingivitis.

Authors:  H R Gaumer; P Holm-Pedersen; L E Folke
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

7.  In vitro stimulation of hamster lymphocytes with concanavalin A.

Authors:  S B Singh; S S Tevethia
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

8.  Alpha-fetoprotein synthesis by murine lymphoid cells in allogeneic reactions.

Authors:  R H Keller; T B Tomasi
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.